NDC 67457-756 – Octreotide Acetate
· Kit
Product NDC67457-756
Product details
- Brand name
- Octreotide Acetate
- Generic name
- Octreotide Acetate
- Labeler
- Mylan Institutional LLC
- Dosage form
- Kit
- Marketing category
- ANDA · ANDA216589
- Marketed since
- January 28, 2026
- Listing expires
- December 31, 2027
Active ingredients
Uses, dosage, side effects and warnings for Octreotide Acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67457-756-10 | 1 KIT in 1 KIT (67457-756-10) * 6 mL in 1 VIAL (67457-754-10) * 2 mL in 1 SYRINGE (67457-755-02) | Jan 28, 2026 |
Other Octreotide Acetate products
- 67457-762 · Kit · Mylan Institutional LLC
- 67457-759 · Kit · Mylan Institutional LLC
- 0480-9257 · Kit · Teva Pharmaceuticals, Inc.
- 0480-9259 · Kit · Teva Pharmaceuticals, Inc.
- 0480-9262 · Kit · Teva Pharmaceuticals, Inc.
- 68083-516 Octreotide Acetate 1000 ug/mL · Injection, Solution · Gland Pharma Limited
- 68083-515 Octreotide Acetate 200 ug/mL · Injection, Solution · Gland Pharma Limited
- 68083-517 Octreotide Acetate 100 ug/mL · Injection, Solution · Gland Pharma Limited
- 68083-560 Octreotide Acetate 500 ug/mL · Injection, Solution · Gland Pharma Limited
- 68462-896 Octreotide Acetate 100 ug/mL · Injection, Solution · GLENMARK PHARMACEUTICALS INC., USA
- 68462-897 Octreotide Acetate 500 ug/mL · Injection, Solution · GLENMARK PHARMACEUTICALS INC., USA
- 52958-046 Octreotide Acetate 100 ug/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.